# Jikei Optimal Insulin Therapy in Type 2 Diabetes

> **NCT00348231** · NA · UNKNOWN · sponsor: **Jikei University School of Medicine** · enrollment: 60 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** dual-action insulin analog

## Key facts

- **NCT ID:** NCT00348231
- **Lead sponsor:** Jikei University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348231, "Jikei Optimal Insulin Therapy in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00348231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*